Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2017 Filed May 10, 2017 20:25 UTC |
Yates Timothy TDirector
|
PurchaseCommon Stock | 3,000 | $35.34 | $106,031.10 |
DisclosureSEC source: 0001209191-17-031261 · doc4.xml · nonDerivative · entry 1 Yates Timothy T · CIK 0001354697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,067 F1 · balance_after: As previously reported, includes 4,470 restricted stock units granted on May 5, 2017 pursuant to the issuer's non-employee director compensation plan, which will vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:27 UTC |
KRAUSE L WILLIAMDirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030945 · doc4.xml · nonDerivative · entry 1 KRAUSE L WILLIAM · CIK 0001055438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,064 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:21 UTC |
GRAY STEPHEN CDirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030936 · doc4.xml · nonDerivative · entry 1 GRAY STEPHEN C · CIK 0001140860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,064 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 16:16 UTC |
ADAMS AUSTIN ADirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030924 · doc4.xml · nonDerivative · entry 1 ADAMS AUSTIN A · CIK 0001195339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,146 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:33 UTC |
Manning TomDirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030951 · doc4.xml · nonDerivative · entry 1 Manning Tom · CIK 0001343053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,306 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vests on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:30 UTC |
Maguire Joanne MDirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030947 · doc4.xml · nonDerivative · entry 1 Maguire Joanne M · CIK 0001368472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,309 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vests on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:38 UTC |
Yates Timothy TDirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030961 · doc4.xml · nonDerivative · entry 1 Yates Timothy T · CIK 0001354697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,067 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:35 UTC |
Watts Claudius E. IVDirector
|
GrantCommon Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030955 · doc4.xml · nonDerivative · entry 1 Watts Claudius E. IV · CIK 0001408738 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,623 F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vests on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date. F2 · balance_after: As previously reported, includes 1,153 restricted stock units granted on January 23, 2017 pursuant to the issuer's non-employee director compensation plan, which will vest on January 23, 2018, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| May 01, 2017 Filed May 2, 2017 09:26 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 15,000 | $42.18 | $632,712.00 |
DisclosureSEC source: 0001209191-17-029067 · doc4.xml · nonDerivative · entry 1 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,284,744 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016. F2 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $41.98 to $42.29. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 16:28 UTC |
WYATT FRANK B IISVP, General Counsel & Sec
|
Exercise / conversionCommon Stock (Right to Buy) · Derivative | 130,356 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001209191-17-026687 · doc4.xml · derivative · entry 6 WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 130,356 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 16:28 UTC |
WYATT FRANK B IISVP, General Counsel & Sec
|
SaleCommon Stock | 130,356 | $40.58 | $5,289,533.63 |
DisclosureSEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 4 WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,675 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017. F4 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.25 to $40.74. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 16:28 UTC |
WYATT FRANK B IISVP, General Counsel & Sec
|
Exercise / conversionCommon Stock | 130,356 | $5.74 | $748,243.44 |
DisclosureSEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 3 WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017. F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:28 UTC |
WYATT FRANK B IISVP, General Counsel & Sec
|
Exercise / conversionCommon Stock (Right to Buy) · Derivative | 125,544 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001209191-17-026687 · doc4.xml · derivative · entry 5 WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,356 Underlying: Common Stock · 125,544 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:28 UTC |
WYATT FRANK B IISVP, General Counsel & Sec
|
SaleCommon Stock | 125,544 | $40.68 | $5,107,619.54 |
DisclosureSEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 2 WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,675 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017. F3 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.46 to $41.07. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:28 UTC |
WYATT FRANK B IISVP, General Counsel & Sec
|
Exercise / conversionCommon Stock | 125,544 | $5.74 | $720,622.56 |
DisclosureSEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 1 WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017. F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 16:32 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 15,000 | $41.63 | $624,435.00 |
DisclosureSEC source: 0001209191-17-024794 · doc4.xml · nonDerivative · entry 1 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,299,744 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016. F2 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $41.37 to $41.89. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 20, 2017 Filed Mar 20, 2017 17:16 UTC |
Edwards Marvin S JrDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 96,200 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001209191-17-021775 · doc4.xml · derivative · entry 6 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,033 Underlying: Common Stock · 96,200 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016. Read SEC document |
| March 20, 2017 Filed Mar 20, 2017 17:16 UTC |
Edwards Marvin S JrDirector · President and CEO
|
SaleCommon Stock | 96,200 | $40.04 | $3,852,242.42 |
DisclosureSEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 4 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,034 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016. F4 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.00 to $40.18. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 20, 2017 Filed Mar 20, 2017 17:16 UTC |
Edwards Marvin S JrDirector · President and CEO
|
Exercise / conversionCommon Stock | 96,200 | $5.74 | $552,188.00 |
DisclosureSEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 3 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016. F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 17:16 UTC |
Edwards Marvin S JrDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,800 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001209191-17-021775 · doc4.xml · derivative · entry 5 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515,233 Underlying: Common Stock · 3,800 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 17:16 UTC |
Edwards Marvin S JrDirector · President and CEO
|
SaleCommon Stock | 3,800 | $40.03 | $152,117.42 |
DisclosureSEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 2 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,034 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016. F3 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.01 to $40.11. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 17:16 UTC |
Edwards Marvin S JrDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,800 | $5.74 | $21,812.00 |
DisclosureSEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 1 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016. F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:42 UTC |
Yates Timothy TDirector
|
PurchaseCommon Stock | 2,000 | $39.45 | $78,899.80 |
DisclosureSEC source: 0001209191-17-017641 · doc4.xml · nonDerivative · entry 1 Yates Timothy T · CIK 0001354697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,597 F1 · balance_after: As previously reported, includes 4,230 restricted stock units granted on May 6, 2016 pursuant to the issuer's non-employee director compensation plan, which will vest on May 6, 2017, subject to the director's continued membership on the Board of Directors on such date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:22 UTC |
OLSON MARK AEVP and CFO
|
Exercise / conversionCommon Stock (Right to Buy) · Derivative | 15,698 | $0.00 Strike: $5.57 | $0.00 |
DisclosureSEC source: 0001209191-17-017521 · doc4.xml · derivative · entry 6 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,698 shares Expires 2021-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:22 UTC |
OLSON MARK AEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,302 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001209191-17-017521 · doc4.xml · derivative · entry 5 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,141 Underlying: Common Stock · 14,302 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:22 UTC |
OLSON MARK AEVP and CFO
|
SaleCommon Stock | 2,700 | $39.46 | $106,536.87 |
DisclosureSEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 4 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,870 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016. F4 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.37 to $39.67. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:22 UTC |
OLSON MARK AEVP and CFO
|
SaleCommon Stock | 27,300 | $39.00 | $1,064,577.15 |
DisclosureSEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 3 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,570 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016. F3 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.33. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:22 UTC |
OLSON MARK AEVP and CFO
|
Exercise / conversionCommon Stock | 15,698 | $5.57 | $87,437.86 |
DisclosureSEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 2 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016. F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:22 UTC |
OLSON MARK AEVP and CFO
|
Exercise / conversionCommon Stock | 14,302 | $5.74 | $82,093.48 |
DisclosureSEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 1 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016. F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 4,200 | $39.46 | $165,739.98 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 12 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Marital Trust Disclosed balance after: 134,383 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F15 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.34 to $39.63. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 46,193 | $39.00 | $1,801,619.39 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 11 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Marital Trust Disclosed balance after: 138,583 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F14 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.32. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 950 | $39.40 | $37,430.48 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 10 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 18,000 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F13 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.29 to $39.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 5,800 | $38.97 | $226,000.48 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 9 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 18,950 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F12 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.27 to $39.26. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 900 | $39.49 | $35,539.02 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 8 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 32,400 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F11 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.38 to $39.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 11,250 | $39.01 | $438,810.75 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 7 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 33,300 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F10 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.32. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 1,100 | $39.46 | $43,405.01 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 6 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 32,400 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F9 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.37 to $39.56. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 11,050 | $38.99 | $430,805.25 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 5 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 33,500 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F8 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.35 to $39.31. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 800 | $39.49 | $31,593.04 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 4 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 32,400 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F7 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.38 to $39.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 11,350 | $39.01 | $442,727.18 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 3 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 33,200 F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016. F6 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.35 to $39.32. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 1,721 | $39.43 | $67,852.15 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 2 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,314,774 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016. F4 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.34 to $39.63. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:19 UTC |
DRENDEL FRANK MDirector
|
SaleCommon Stock | 13,279 | $39.00 | $517,875.69 |
DisclosureSEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 1 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,316,495 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016. F2 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.33. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction. F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:43 UTC |
Mingle Robyn TSVP of CommScope, Inc.
|
GrantStock Option (Right to Buy) · Derivative | 12,730 | $0.00 Strike: $37.97 | $0.00 |
DisclosureSEC source: 0001209191-17-015923 · doc4.xml · derivative · entry 2 Mingle Robyn T · CIK 0001531828 · SVP of CommScope, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,730 Underlying: Common Stock · 12,730 shares Expires 2027-02-27 F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:43 UTC |
Mingle Robyn TSVP of CommScope, Inc.
|
GrantCommon Stock | 5,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015923 · doc4.xml · nonDerivative · entry 1 Mingle Robyn T · CIK 0001531828 · SVP of CommScope, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,241 F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. F2 · balance_after: As previously reported, includes (a) 3,605 restricted stock units that were granted on 08/01/2016 and will vest ratably on 02/23/2018 and 02/23/2019; and (b) 6,250 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:35 UTC |
Edwards Marvin S JrDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 148,525 | $0.00 Strike: $37.97 | $0.00 |
DisclosureSEC source: 0001209191-17-015891 · doc4.xml · derivative · entry 2 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,525 Underlying: Common Stock · 148,525 shares Expires 2027-02-27 F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:35 UTC |
Edwards Marvin S JrDirector · President and CEO
|
GrantCommon Stock | 61,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015891 · doc4.xml · nonDerivative · entry 1 Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,034 F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:45 UTC |
OLSON MARK AEVP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 31,826 | $0.00 Strike: $37.97 | $0.00 |
DisclosureSEC source: 0001209191-17-015929 · doc4.xml · derivative · entry 2 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,826 Underlying: Common Stock · 31,826 shares Expires 2027-02-27 F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:45 UTC |
OLSON MARK AEVP and CFO
|
GrantCommon Stock | 13,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015929 · doc4.xml · nonDerivative · entry 1 OLSON MARK A · CIK 0001189817 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,870 F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. F2 · balance_after: As previously reported, includes (a) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (d) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:15 UTC |
DRENDEL FRANK MDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,764 | $0.00 Strike: $37.97 | $0.00 |
DisclosureSEC source: 0001209191-17-015833 · doc4.xml · derivative · entry 7 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,764 Underlying: Common Stock · 23,764 shares Expires 2027-02-27 F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:15 UTC |
DRENDEL FRANK MDirector
|
GrantCommon Stock | 9,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015833 · doc4.xml · nonDerivative · entry 1 DRENDEL FRANK M · CIK 0001196634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,329,774 F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. F2 · balance_after: As previously reported, includes (a) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (d) 4,655 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 16:12 UTC |
CRENSHAW RANDALL WEVP and COO
|
GrantStock Option (Right to Buy) · Derivative | 36,070 | $0.00 Strike: $37.97 | $0.00 |
DisclosureSEC source: 0001209191-17-015827 · doc4.xml · derivative · entry 2 CRENSHAW RANDALL W · CIK 0001210245 · EVP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,070 Underlying: Common Stock · 36,070 shares Expires 2027-02-27 F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.